Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Knowledge@Wharton January 29, 2003	China Can Help the U.S. Tackle Its Social Security Crisis Much has been written about the looming pension crisis in the U.S., Europe and Japan, whose populations are aging. Wharton finance professor Jeremy J. Siegel argues that economic growth in China and the rest of the developing world holds the key to dealing with the impending crunch.
IndustryWeek September 1, 2007 Thomas J. Duesterberg	The Competitive Edge -- When It Comes To The Economy, Population Matters Based on demographic trends, Asia's population could grow to become the most productive in the world.
Knowledge@Wharton	How Wealthy Nations Can Avoid a Looming Retirement Crisis The extent of the global aging problem and the prospect for globally-based solutions were outlined during a conference several weeks ago on "Risk Transfers and Retirement Income Security."
The Motley Fool September 23, 2010 Jared Cummans	Three ETFs to Play the Coming Emerging Market Infrastructure Boom More investors have grown unsure of the economic future in much of the developed world, and many have flocked toward emerging markets.
The Motley Fool January 11, 2010 Nick Kapur	Avoid the Iceberg That Could Sink Your Portfolio Investors must face the dawn of a new era, one that may bring with it heavy and unprecedented declines in consumer strength and labor power.
The Motley Fool July 31, 2009 Brian Orelli	Can Emerging Markets Save Pharma? Probably not until after they emerge.
The Motley Fool September 30, 2011 David Williamson	This Week in Health Care Pharma news about Pfizer, AstraZeneca, and the multibillion-dollar battle to replace the maligned blood-thinner warfarin.
The Motley Fool February 28, 2008 Brian Lawler	Medicare, Health Care, and Megabucks A new government report forecasts big growth in health-care spending in the next ten years, meaning there will be some major growth opportunities in the pharmaceutical sector.
The Motley Fool December 6, 2004 Brian Gorman	Pill-Popping Nation Americans are using more prescription drugs. Unfortunately for big pharma investors, pharmaceutical companies' benefits from these trends are tempered by other factors.
The Motley Fool December 9, 2011 Paul Chi	3 Europe-Proof Stocks for Your Portfolio These health-care stocks are Europe-proof.
Finance & Development June 2011	The Price of Maturity Aging populations mean countries have to find new ways to support their elderly.
The Motley Fool September 5, 2006 Will Frankenhoff	You Can't Afford Not To People often talk about the risks involved with investing in emerging markets. But given the current trends, can you really afford not to have at least some exposure to emerging market equities?
BusinessWeek January 31, 2005 Michael J. Mandel	Productivity Can Make Up The Gap Demographics will not mean doom if we focus on fostering innovation.
Pharmaceutical Executive September 1, 2013 William Looney	High Noon For Hot Markets Fading growth, overstretched governments, and a global governance backlash against pharma business are turning up the heat on the performance of emerging country markets.
The Motley Fool November 11, 2004 Brian Gorman	Hospira's Possibilities The medical products and services outfit is not flashy, but it may benefit from long-term trends. Their stock may be worth monitoring.
Registered Rep. May 10, 2012 Jennifer Duell Popovec	Emerging Real Estate in Emerging Markets While most investors lack a deep understanding of emerging markets overall, most of them know enough to be excited about these countries and the investment opportunities they offer.
The Motley Fool January 7, 2010 Brian Orelli	Pfizer Strides Farther Into Generics Pfizer's new look might be just what the doctor ordered.
The Motley Fool August 4, 2010 Amanda B. Kish	3 Big Bets on Health Care As Americans age, funds heavy in health care could really pay off.
Investment Advisor November 2006	Remarks by Chairman Ben S. Bernanke The Coming Demographic Transition: Will We Treat Future Generations Fairly? -- Over the next few decades, the U.S. population will grow significantly older, a development that will affect our society and our economy in many ways.
The Motley Fool November 5, 2004 Roger Nusbaum	The Tale of Teva Generic drug companies like Teva may offer a smart way to own health care. However, the company's good fortune hit a bump when rival Andrx got pummeled with a bad earnings announcement, and Teva traded down in sympathy.
Investment Advisor April 2008 Kara P. Stapleton	Transforming the Dependency Ratio Between 2005-2050 the amount of baby boomers will be swelling the senior crowd, and the "dependency ratio" -- the relationship between the size of the working-age population and the elderly -- will rise.
The Motley Fool May 4, 2011 Jason Knapp	Generic Drugs and Old People Could Make You Rich CVS hasn't generated market-beating returns yet -- but it will.
Pharmaceutical Executive December 1, 2010 Zhu Shen	China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda
The Motley Fool September 1, 2010 Eric Dutram	Three International ETFs Facing Shrinking Populations Take a look at three country-specific ETFs that could face headwinds created by a shrinking population going forward.
The Motley Fool March 8, 2011 Zeeshan Siddique	Health-Care REITs Are Prepared to Catapult With lots of acquisitions and investments, health-care REITs are riding high.
Finance & Development September 1, 2006 Bloom & Canning	Booms, Busts, and Echoes Since 1870 death rates and birth rates have been declining in developed countries. Here's how the biggest demographic upheaval in history is affecting global economic development.
Chemistry World July 25, 2012	Pharma Industry May Suffer as India Looks to Generics India plans to provide free generic drugs to half its population.
The Motley Fool March 30, 2011 Sean Williams	China Clamps Down on Drug Manufacturers These drug manufacturers could be feeling a pinch from new Chinese price caps.
The Motley Fool August 29, 2011 John Maxfield	Asia May Make These 2 Companies Very Rich How you can profit from the demographic trends in China. Heavy equipment manufacturers Deere and Caterpillar are both positioning themselves to benefit from these trends.
The Motley Fool April 5, 2011 Frank Vinluan	GSK in Emerging Markets: Why Sales Staff There Are Key to Global Strategy GlaxoSmithKline's rivalry with top drug companies such as Pfizer goes beyond the products they sell. In some emerging markets, it now also extends to the staff they're fighting to keep.
The Motley Fool December 27, 2011 Dan Caplinger	Why Emerging Markets Fell Apart in 2011 Will hot countries come back next year?
The Motley Fool November 19, 2009 Brian Orelli	Pfizer's Generic Growth, With a Side of Sashimi A move into Japan isn't a bad idea, but it isn't going to save the company either.
BusinessWeek January 13, 2011 Peter Coy	If Demography Is Destiny, Then India Has the Edge Research from HSBC and Standard Chartered shows the U.S. and other industrialized nations slipping while some surprising leaders emerge.
The Motley Fool January 3, 2007 Will Frankenhoff	China Life: Expect Another Premium Performance The company's dominant share of an underdeveloped market, the potential growth of that market due to the rapid aging of China's population, and the likelihood of increasing investment yields, should convince investors to stay the course with China Life, despite its relatively lofty valuation.
Chemistry World May 21, 2009 Matt Wilkinson	Big Pharma set for generics boost Pharmaceutical firms have been rushing to ensure they minimize their losses by expanding their generics businesses and reach into emerging markets.
The Motley Fool October 18, 2010 Brian Orelli	Pfizer Flexes Its Generic Muscles The pharma giant moves farther into generic drugs.
Finance & Development September 1, 2006 Bryant & Sonerson	Gauging the Cost of Aging Why population aging is not the main cause of rising government health expenditure in New Zealand.
The Motley Fool April 14, 2005 Brian Gorman	Novartis Moves on Multiple Fronts Even with its investment in a potential blockbuster, Novartis remains remarkably diversified. Investors can rest assured, though, that the company's strategy won't leave it as vulnerable as other outfits.
The Motley Fool November 12, 2009 Dan Caplinger	Will the Baby Boom Spell Doom for Stocks? Retiring boomers will need cash. Will they dump their assets en masse?
AFP eWire August 9, 2004	A "Golden Age for Philanthropy" Ahead? The July 29 issue of The Economist predicts that another golden age for philanthropy and charitable giving is about to occur not only in the United States, but also around the world.
Pharmaceutical Executive August 1, 2011 Ben Comer	Is the 'Emerging Market' a Dated Concept? When it comes to the emerging markets, executing a few key elements of success are more important than ever.
Pharmaceutical Executive February 1, 2011 William Looney	Tracking the US Market: A Statistical Self-Portrait What are some of the essential characteristics of the US market? Statistics drawn from the 2011 Statistical Abstract of the US shed some light
BusinessWeek January 31, 2005 Engardio & Matlack	Global Aging It's not just Europe -- China and other emerging-market economies are aging fast, too. There are solutions, but it's time to act.
The Motley Fool October 11, 2011 Cliff D'Arcy	AstraZeneca Loves This $100Bn Market The British pharma firm makes its largest-ever manufacturing investment -- in China.
Pharmaceutical Executive February 1, 2011 Jon Zifferblat	China: Business as UNusual If there is one market that requires a click on the 'refresh' button, it's China. General Biologic provides a snapshot of what's ahead for Big Pharma in the country
IndustryWeek September 1, 2008 Thomas J. Duesterberg	The Competitive Edge -- Looking Ahead to Manufacturing's Future Growth in U.S. manufacturing will be led by exports, capital investment and growth abroad.
The Motley Fool March 24, 2009 Robert Steyer	Drugmakers Diversify -- Again Merck and Pfizer choose businesses they once eschewed.
The Motley Fool October 21, 2008 Brian Orelli	The World Is Saving Pfizer The pharma company experienced a double-digit decrease in U.S. sales in the third quarter. Ouch.
Finance & Development June 2011	Keeping Smart about the Older Generation Aging populations could throw into question the ability of many countries to provide a decent standard of living for the old without imposing a crushing burden on the young.
Science News February 2, 2008 Julie J. Rehmeyer	Math Trek: Getting Old, Faster and Faster The world population is aging fast, but is still younger than we tend to think.